| Accession Number: | 0001209191-21-058157 |
| Date: | 2021-09-30 |
| Issuer: | ROYALTY PHARMA PLC (RPRX) |
| Original Submission Date: |
BASSLER BONNIE L
C/O ROYALTY PHARMA PLC
110 E. 59TH STREET
NEW YORK, NY 10022
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| CLASS A ORDINARY SHARES | 2021-09-30 | A | 992 | a | $37.80 | 22,772 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | reflects class a ordinary shares issued to the reporting person under the issuer's 2020 independent director equity incentive plan in lieu of a quarterly retainer payment of $37,500. |
